What Cancer
Can and Can't do
New approach to fighting cancer could reduce costs ...
OCTOBER 20, 2020 by Kathy Sharrad, University of South Australia UniSA's Future Industries Institute Ph.D. student Mona Elsemary has dev ...more
U.S. incidence of distant-stage prostate cancer up ...
OCTOBER 16, 2020 U.S. incidence of distant-stage prostate cancer up, 2010 to 2017 (HealthDay)—Although three-fourths of U.S. prostate canc ...more
Many male breast cancers diagnosed late, and delay ...
OCTOBER 15, 2020 by E.j. Mundell, Healthday Reporter Many male breast cancers diagnosed late, and delays can be lethal (HealthDay)—Brea ...more
View All 
Events Back
Monday, March 1, 2021  to   Monday, March 1, 2021
National Educational Webinar For Women With Ovarian Cancer
Webinar- Noon-1PM EST
National Educational Webinar For Women With Ovarian Cancer

WHEN: Monday, March 1. Noon- 1pm (NY time)
WHERE: National Webinar

Open to women nationwide who have or have had ovarian cancer. Pre-registration is required. To register, call Support Connection, 914-962-6402 or 800-532-4290. Must register no later than 5 pm (NY time) on Fri., Feb. 26

The focus of this educational webinar will be Genetics and Genomics of Ovarian Cancer. Genetics refers to the study of genes and the way that certain traits or conditions are passed down from one generation to another. Genomics describes the study of all of a person’s genes (the genome).

Topics will include:

The latest research on genetics and genomics for ovarian cancer
How does your genetics affect treatment?
The importance and role of genomics as it pertains to treatment
PARP Inhibitors
The importance of genetics for family members
Following the presentation, there will be a question and answer period.

SPEAKER: Melissa Frey, M.D. Assistant Professor of Obstetrics and Gynecology in the division of gynecologic oncology at Weill Cornell Medicine. Dr. Frey specializes in all aspects of gynecologic oncology. Her research focuses on genetics and genomics in gynecologic cancer. She has presented her research at national and international meetings and has more than 50 publications in peer-reviewed scientific journals. Much of Dr. Frey’s research has focused on genetic syndromes that predispose to gynecologic cancer including hereditary breast and ovarian cancer (BRCA1/BRCA2) and Lynch syndrome.

Dr. Frey graduated magna cum laude from Duke University and earned her medical degree from Weill Cornell Medical College, graduating with honors in research. She completed her residency in Obstetrics and Gynecology at Weill Cornell Medicine / NewYork-Presbyterian. She subsequently completed her fellowship in gynecologic oncology at New York University Langone Medical Center. Dr. Frey has received numerous awards for her clinical excellence, surgical expertise and medical research, as well as many teaching awards.